The independent valuation report has not delivered any particular surprises for the hardcore TAP investors. Clearly this company has cleaned up their balance sheet and for a couple of quarters it is generating free cash, so that is a good thing. They also have a better cash buffer now so that should add a few more cents to the stock price. Improvement in the production of Manora is also evident, albeit there is limited production life till around 2022-2023.
They will need to find another project that will convert to production. That may need them to latch onto another mid-tier or large producer since they have a small cash reserve to effect a meaningful exploration campaign to generate resources and convert to reserves and production.
All in all, I am glad that I held on quite a bit during these rather unpleasant 3 years.
- Forums
- ASX - By Stock
- TAP
- Ann: Supplementary Target's Statement
Ann: Supplementary Target's Statement, page-2
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online